Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,824 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06735664RecruitingPhase 1
Zanubrutinib and odronextamab for Richter's transformation
This trial tests a combination of two targeted drugs for people with Richter's transformation, an aggressive lymphoma that can develop from CLL. The goal is to see if this combination can help control the disease.
Duarte, CaliforniaAges 18 years+ - NCT06776380Recruiting
Puberty development in people with RASopathies
This study looks at how puberty develops in people with RASopathies. It aims to understand the process better by studying those who have already completed puberty.
Bologna, BolognaAges 8–35 - NCT06693596Recruiting
Ovarian mass study for girls and teens up to age 20
This study collects information on ovarian masses in young patients to improve diagnosis. If you are 20 or younger and have a newly found mass on an ovary, you may join to help researchers learn more about these growths.
LeuvenAges birth–20 years - NCT06653777RecruitingPhase 2
Pemigatinib for FGFR-altered advanced solid tumors
This trial tests a targeted drug called pemigatinib for advanced solid tumors that have a specific change in the FGFR gene. The goal is to see if the drug can slow tumor growth for people who have few other treatment options.
BrestAges 18 years+ - NCT06643975Recruiting
Comparing tooth implants for lower jaw overdentures
This study compares patient satisfaction and bone changes around two types of dental implants used to support a removable lower denture. It may help you understand which implant material works best for you.
CairoAges 50–60 - NCT06623032Recruiting
Medium-chain fatty acids in MCADD patients and healthy volunteers
This trial tests how medium-chain fatty acids (a type of fat found in coconut oil) affect metabolism in people with MCADD, a genetic condition that affects fat breakdown, compared to healthy people. The results may help guide dietary advice for those with MCADD.
CopenhagenAges 18–80 - NCT06692868Recruiting
Fertility protection for young cancer patients
This trial offers fertility preservation options for children, teens, and young adults diagnosed with cancer or undergoing stem cell transplant before age 21, to help protect their ability to have biological children in the future.
Ulm, Baden-WurttembergAges Any age - NCT06662760RecruitingPhase 1
TQB3002 for advanced cancers when standard treatments fail
This trial tests an experimental oral drug called TQB3002 for people with advanced solid tumors who have run out of standard options. Researchers are learning the best dose and how safe it is, with the hope of controlling or shrinking the cancer.
Guangzhou, GuangdongAges 18 years+ - NCT06664476Recruiting
Learning better port-a-catheter care for chemo
This trial teaches nurses how to better care for a port-a-catheter (a small device placed under the skin to give chemotherapy). It looks at whether special training helps nurses improve their skills. If you are a nurse with at least one year of experience in an oncology unit, this might be for you.
CairoAges Any age - NCT06656117Enrolling by invitation
Elliptical vs. resistance training for heart bypass recovery
This study compares elliptical training with resistance training to see which better improves heart and lung function in patients who have had coronary artery bypass grafting (CABG). It aims to help you recover more fully during phase III cardiac rehab.
Sialkot, Punjab ProvinceAges 45–55 - NCT06632574RecruitingPhase 1
Paclitaxel liposomes via artery for advanced solid tumors
This trial tests a new form of paclitaxel (a chemotherapy drug) wrapped in tiny fat bubbles called liposomes. It is given directly into an artery that feeds the tumor, which may deliver the drug more effectively to the cancer. The study is for people with advanced solid tumors that can be treated this way, such as stomach, liver, pancreatic, or lung cancers.
NanjingAges 18 years+ - NCT06657391RecruitingPhase 2
Study of a new drug to prevent graft-versus-host disease in thalassemia patients
This trial tests a drug called an anti-CD25 antibody to see if it can prevent graft-versus-host disease (a condition where donor cells attack the body) in people with transfusion-dependent thalassemia who are getting a stem cell transplant from a partially matched or unrelated donor.
Maoming, GuangdongAges 3–20 - NCT06622486RecruitingPhase 1/Phase 2
EGL-001 for advanced solid tumors after immunotherapy
This trial tests a new drug called EGL-001 for people with advanced solid tumors that have already been treated with immunotherapy. The goal is to see if the drug is safe and effective against cancer that has not responded to other treatments.
DijonAges 18 years+ - NCT06646536Recruiting
Anti-gravity treadmill for meniscus tear recovery
This trial tests whether walking on an anti-gravity treadmill helps people recover from a meniscus tear better than standard care. It may reduce pain and improve knee function.
Istanbul, EyupAges 18–40 - NCT06694259Recruiting
Laser vs. freezing for retinal detachment repair
This trial compares two methods (laser or freezing) to seal tears in the retina after a procedure to reattach it. It may help people with a specific type of retinal detachment where the tear is in the upper part of the eye.
SplitAges 18 years+ - NCT06656182Recruiting
Mobilization techniques for scapulocostal syndrome
This trial tests two types of gentle joint movements (SNAGs and scapular mobilizations) to see if they reduce pain and improve shoulder and neck movement in people with scapulocostal syndrome. If you have chronic neck pain and trouble lifting your arm overhead, this study may help.
Rawalpindi, Punjab ProvinceAges 18–40 - NCT06654154Recruiting
Vitamin B12 as a marker for disease activity in tocilizumab patients
This study looks at whether vitamin B12 levels in the blood can help tell if your disease is active or if you have an infection while being treated with tocilizumab. The goal is to find a simple way to monitor your condition without extra invasive tests.
Clermont-FerrandAges 18 years+ - NCT06616129Recruiting
Geriatric risk assessment for older heart surgery patients
This study tests whether a special geriatric risk assessment and shared decision-making conversation helps older patients (70+) and their doctors choose the best treatment for heart surgery. It aims to improve quality of life by tailoring decisions to each person's health risks.
Groningen, Provincie GroningenAges 70 years+ - NCT06629766Recruiting
Study on how father's age affects embryo growth
This study looks at how the father's age might affect the growth of embryos in the lab. It is for couples doing their first IVF cycle, planning to test embryos for genetic health before freezing them, and then transferring one healthy embryo.
Basking Ridge, New JerseyAges 18–41 - NCT06689111Recruiting
Heart resynchronization method study for patients with LBBB and heart failure
This study compares two ways to resynchronize the heart's pumping in people with heart failure and a specific heart block (LBBB). It uses special ultrasound imaging to see which method works better for improving heart function.
Pátrai, GreeceAges 18–90 - NCT06683781Recruiting
Breathing machine settings and weaning success study
This study looks at how breathing machine settings and monitoring can help predict if a patient will successfully come off the ventilator. It may help doctors choose better settings for patients who are ready to try breathing on their own.
Buenos AiresAges 18–100 - NCT06662097RecruitingPhase 2
Bevonescein in abdominopelvic surgery
This trial tests a dye called Bevonescein that may help surgeons see nerves and other tissues more clearly during abdominal or pelvic surgery. It might lead to safer procedures.
San Diego, CaliforniaAges 18 years+ - NCT06661291Recruiting
Using Pip App to Help Surgery Recovery
This study tests a smartphone app called Pip that helps you prepare for and recover from surgery. It is for people who have certain types of planned surgeries, like abdominal, spine, or joint replacement, and have a smartphone or tablet.
New Castle, PennsylvaniaAges 18 years+ - NCT06647836Enrolling by invitation
Immunotherapy for advanced lung squamous cancer
This trial tests how well immunotherapy works as a first treatment for advanced lung squamous cell carcinoma, either alone or with chemotherapy. It aims to see if this approach can help patients who haven't had prior cancer treatment.
Wuhan, HubeiAges 18–80
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,824 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.